Sino Biopharmaceutical
1177.HK
#2005
Rank
โ‚น666.58 B
Marketcap
โ‚น36.61
Share price
3.36%
Change (1 day)
-10.29%
Change (1 year)
Sino Biopharmaceutical is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.

Revenue for Sino Biopharmaceutical (1177.HK)

Revenue in 2021 (TTM): โ‚น283.95 Billion

According to Sino Biopharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚น324.84 Billion. In 2020 the company made a revenue of โ‚น251.17 Billion an increase over the revenue in the year 2019 that were of โ‚น249.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sino Biopharmaceutical from 2011 to 2021

Annual revenue

Year Revenue Change
2021 (TTM) โ‚น283.95 B13.05%
2020 โ‚น251.17 B0.56%
2019 โ‚น249.77 B14.1%
2018 โ‚น218.91 B55.28%
2017 โ‚น140.98 B-2.56%
2016 โ‚น144.68 B12.65%
2015 โ‚น128.43 B26.63%
2014 โ‚น101.42 B29.97%
2013 โ‚น78.03 B33.76%
2012 โ‚น58.34 B51.24%
2011 โ‚น38.57 B